acm research inc - ACMR
ACMR
Close Chg Chg %
53.22 0.14 0.26%
Closed Market
53.36
+0.14 (0.26%)
Volume: 1.42M
Last Updated:
Jan 12, 2026, 4:00 PM EDT
Company Overview: acm research inc - ACMR
ACMR Key Data
| Open $52.50 | Day Range 52.30 - 54.74 |
| 52 Week Range 14.97 - 54.74 | Market Cap $3.45B |
| Shares Outstanding 64.88M | Public Float 54.22M |
| Beta 1.45 | Rev. Per Employee N/A |
| P/E Ratio 31.11 | EPS $1.84 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.34M |
ACMR Performance
| 1 Week | 0.26% | ||
| 1 Month | 37.42% | ||
| 3 Months | 45.83% | ||
| 1 Year | 241.61% | ||
| 5 Years | 69.22% |
ACMR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
8
Full Ratings ➔
About acm research inc - ACMR
ACM Research, Inc. engages in the development, manufacture, and sale of single-wafer wet cleaning equipment. It supplies process solutions that semiconductor manufacturers can use in numerous manufacturing steps to remove particles, contaminants and other random defects, and thereby improve product yield. The company tools can be used in fabricating foundry, logic and memory chips including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company was founded by David H. Wang and Hui Wang in January 1998 and is headquartered in Fremont, CA.
ACMR At a Glance
ACM Research, Inc.
42307 Osgood Road
Fremont, California 94539
| Phone | 1-510-445-3700 | Revenue | 782.12M | |
| Industry | Industrial Machinery | Net Income | 103.63M | |
| Sector | Producer Manufacturing | 2024 Sales Growth | 40.234% | |
| Fiscal Year-end | 12 / 2025 | Employees | 2,023 | |
| View SEC Filings |
ACMR Valuation
| P/E Current | 31.11 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 9.863 |
| Price to Sales Ratio | 1.279 |
| Price to Book Ratio | 1.051 |
| Price to Cash Flow Ratio | 6.56 |
| Enterprise Value to EBITDA | 5.792 |
| Enterprise Value to Sales | 1.192 |
| Total Debt to Enterprise Value | 0.202 |
ACMR Efficiency
| Revenue/Employee | 386,612.951 |
| Income Per Employee | 51,224.419 |
| Receivables Turnover | 1.819 |
| Total Asset Turnover | 0.467 |
ACMR Liquidity
| Current Ratio | 2.313 |
| Quick Ratio | 1.381 |
| Cash Ratio | 0.699 |
ACMR Profitability
| Gross Margin | 50.063 |
| Operating Margin | 19.306 |
| Pretax Margin | 21.263 |
| Net Margin | 13.25 |
| Return on Assets | 6.193 |
| Return on Equity | 12.395 |
| Return on Total Capital | 9.477 |
| Return on Invested Capital | 11.266 |
ACMR Capital Structure
| Total Debt to Total Equity | 20.869 |
| Total Debt to Total Capital | 17.266 |
| Total Debt to Total Assets | 10.173 |
| Long-Term Debt to Equity | 12.09 |
| Long-Term Debt to Total Capital | 10.002 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Acm Research Inc - ACMR
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 259.75M | 388.83M | 557.72M | 782.12M | |
Sales Growth
| +65.84% | +49.69% | +43.44% | +40.23% | |
Cost of Goods Sold (COGS) incl D&A
| 144.90M | 205.22M | 281.51M | 390.56M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 2.35M | 5.37M | 8.09M | 9.97M | |
Depreciation
| 2.10M | 4.84M | 6.91M | 6.57M | |
Amortization of Intangibles
| 254.00K | 527.00K | 1.18M | 3.39M | |
COGS Growth
| +66.50% | +41.63% | +37.18% | +38.74% | |
Gross Income
| 114.86M | 183.62M | 276.21M | 391.55M | |
Gross Income Growth
| +65.03% | +59.87% | +50.43% | +41.76% | |
Gross Profit Margin
| +44.22% | +47.22% | +49.53% | +50.06% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 76.15M | 124.58M | 180.38M | 240.56M | |
Research & Development
| 34.21M | 62.23M | 92.71M | 105.47M | |
Other SG&A
| 41.95M | 62.35M | 87.67M | 135.08M | |
SGA Growth
| +58.30% | +63.59% | +44.79% | +33.36% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| (607.00K) | 7.86M | 2.74M | (973.00K) | |
EBIT after Unusual Expense
| 39.31M | 51.18M | 93.10M | 151.97M | |
Non Operating Income/Expense
| 4.51M | 17.84M | 25.80M | 18.48M | |
Non-Operating Interest Income
| 505.00K | 8.74M | 8.35M | 9.94M | |
Equity in Earnings of Affiliates
| 4.64M | 4.67M | 9.95M | 423.00K | |
Interest Expense
| 765.00K | 1.66M | 2.68M | 4.15M | |
Interest Expense Growth
| -22.10% | +116.34% | +61.99% | +54.83% | |
Gross Interest Expense
| 765.00K | 1.66M | 2.68M | 4.15M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 43.05M | 67.36M | 116.22M | 166.30M | |
Pretax Income Growth
| +123.14% | +56.46% | +72.52% | +43.10% | |
Pretax Margin
| +16.58% | +17.32% | +20.84% | +21.26% | |
Income Tax
| 134.00K | 16.80M | 19.36M | 35.03M | |
Income Tax - Current - Domestic
| 93.00K | 497.00K | 12.91M | 485.00K | |
Income Tax - Current - Foreign
| 2.19M | 11.14M | 19.70M | 29.12M | |
Income Tax - Deferred - Domestic
| (2.09M) | 10.92M | (7.38M) | 5.31M | |
Income Tax - Deferred - Foreign
| (65.00K) | (5.76M) | (5.86M) | 119.00K | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| 4.64M | 4.67M | 9.95M | 423.00K | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 42.92M | 50.56M | 96.85M | 131.27M | |
Minority Interest Expense
| 5.16M | 11.30M | 19.50M | 27.64M | |
Net Income
| 37.76M | 39.26M | 77.35M | 103.63M | |
Net Income Growth
| +101.05% | +3.99% | +97.00% | +33.97% | |
Net Margin Growth
| +14.54% | +10.10% | +13.87% | +13.25% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 37.76M | 39.26M | 77.35M | 103.63M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 37.76M | 39.26M | 77.35M | 103.63M | |
EPS (Basic)
| 0.6549 | 0.6628 | 1.2856 | 1.6657 | |
EPS (Basic) Growth
| +90.77% | +1.21% | +93.96% | +29.57% | |
Basic Shares Outstanding
| 57.65M | 59.24M | 60.16M | 62.21M | |
EPS (Diluted)
| 0.5777 | 0.592 | 1.164 | 1.5309 | |
EPS (Diluted) Growth
| +95.50% | +2.48% | +96.62% | +31.52% | |
Diluted Shares Outstanding
| 65.36M | 65.34M | 64.87M | 66.24M | |
EBITDA
| 41.05M | 64.40M | 103.93M | 160.97M | |
EBITDA Growth
| +82.09% | +56.87% | +61.38% | +54.88% | |
EBITDA Margin
| +15.81% | +16.56% | +18.63% | +20.58% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 42.643 | |
| Number of Ratings | 8 | Current Quarters Estimate | 0.385 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 2.13 | |
| Last Quarter’s Earnings | 0.465 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.845 | Next Fiscal Year Estimate | 2.74 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 6 | 6 | 8 | 5 |
| Mean Estimate | 0.39 | 0.51 | 2.13 | 2.74 |
| High Estimates | 0.50 | 0.63 | 2.65 | 3.30 |
| Low Estimate | 0.25 | 0.33 | 1.50 | 2.30 |
| Coefficient of Variance | 21.47 | 19.81 | 16.27 | 14.62 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 7 | 7 | 7 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 1 | 1 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Acm Research Inc - ACMR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Acm Research Inc - ACMR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Oct 31, 2025 | David H. Wang See Remarks; Director | 545,400 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 10, 2025 | Lisa Feng See remarks | 65,001 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $5.6 per share | 364,005.60 |
| Jul 10, 2025 | Lisa Feng See remarks | 50,001 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $28 per share | 1,400,028.00 |
| Jul 10, 2025 | Lisa Feng See remarks | 30,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 21, 2025 | Chen Ming C. Hu Director | 100,002 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30 per share | 3,000,060.00 |
| Mar 21, 2025 | Hai Ping Dun Director | 762,152 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $28.32 per share | 21,584,144.64 |
| Mar 21, 2025 | Hai Ping Dun Director | 755,090 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $29.23 per share | 22,071,280.70 |
| Mar 17, 2025 | Mark A. McKechnie See Remarks | 15,900 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $5.6 per share | 89,040.00 |
| Mar 17, 2025 | Mark A. McKechnie See Remarks | 900 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $27.42 per share | 24,678.00 |
| Mar 17, 2025 | Mark A. McKechnie See Remarks | 15,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | David H. Wang See Remarks; Director | 747,708 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $26.57 per share | 19,866,601.56 |
| Mar 14, 2025 | David H. Wang See Remarks; Director | 710,208 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $27.42 per share | 19,473,903.36 |
| Mar 14, 2025 | David H. Wang See Remarks; Director | 673,727 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $27.29 per share | 18,386,009.83 |
| Mar 14, 2025 | David H. Wang See Remarks; Director | 672,708 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $27.65 per share | 18,600,376.20 |
| Mar 6, 2025 | David H. Wang See Remarks; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 6, 2025 | Hai Ping Dun Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |